STC-15

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameSTC-15
Drug Alias NameSTC-15STM-3480
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN6-adenosine-methyltransferase catalytic subunit inhibitors
TargetsN6-adenosine-methyltransferase catalytic subunit
Therapy Area/IndicationsSolid tumoursSarcomaLeiomyosarcoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvotecStorm Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEvotec AGStorm Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursSarcomaLeiomyosarcoma +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A